To Test Bioequivalence Between Two Formulations of Paracetamol/Phenylephrine

• Status: Completed
• Trial end date: 2010-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This study is designed to assess bioequivalence between two paracetamol/ phenylephrine combination products.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: McNeil AB
• Treatments: Acetaminophen; Oxymetazoline; Phenylephrine

Criteria

Inclusion Criteria:

• Healthy male and female

• Caucasians

• Aged between 18 and 50 years

• BMI ≤ 30 kg/m2

• Clinically normal medical history

• Physical normal examination

• Normal laboratory test results

Exclusion Criteria:

• Pregnancy, lactation or intended pregnancy

• Hypersensitivity to or intolerant of the study medications

• Donation or loss of blood within 90 days preceding the first dose of study medication